01558 HEC CJ PHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.77X | Oper Margin | 18.1% |
|---|---|---|---|
| LT Debt/Equity | 10.6% | Net Margin | 13.0% |
| Total Debt/Equity | 26.3% | Return on Equity | 5.7% |
| Price/Book | 1.65X | Return on Assets | 3.9% |
| (HKD 16.940) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 513.36 | 2,196.27 | 85.89 | -718.75 | 996.27 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -76.6 | +2,457.2 | +112.0 | -172.1 | -53.6 |
| Earnings Per Share (HKD) | 0.583 | 2.496 | 0.098 | -0.817 | 1.13 |
| Earnings Per Share Growth (%) | -76.6 | +2,457.3 | +112.0 | -172.3 | -53.2 |
| Dividend Per Share (HKD) | 1.500 | No dividend | No dividend | No dividend | 0.114 |
| P/E* (X) | 29.04 | 6.79 | 173.57 | N/A | 14.99 |
| Yield (%) | 8.85 | N/A | N/A | N/A | 0.67 |
| Dividend Share (%) | 257.11 | N/A | N/A | N/A | 10.05 |
| Book NAV (HKD) | 10.283 | 9.940 | 7.498 | 8.073 | 6.597 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 3,724 | 6,295 | -40.8 | 3,745 |
| Operating Result | 566.609 | 2,127 | -73.4 | 40.242 |
| Associates | 0.293 | -0.029 | -1,110.3 | 0 |
| Profit Before Taxation | 577.233 | 2,127 | -72.9 | 39.422 |
| Taxation | 94.521 | 270.945 | -65.1 | -9.817 |
| Profit /( Loss) After Taxation | 482.712 | 1,856 | -74.0 | 49.239 |
| Minority Interests | 0 | -136.798 | -100.0 | -27.364 |
| Net Profit | 482.712 | 1,993 | -75.8 | 76.603 |
| Earnings Per Share () | 0.5834 | 2.4959 | -76.6 | 0.0976 |
| Dividend Per Share () | 1.5000 | 0.0000 | N/A | 0.0000 |
| Announcement Date | 2025-03-28 | 2024-03-28 | NA | 2023-03-24 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
